AbbVie Strengthens Immunology Leadership with $10.9 Billion Apogee Therapeutics Acquisition – Meet them this November

Talawar Therapeutics Heads to Nasdaq via SPAC Deal to Bankroll Eczema Asset

10 Clinical Trials to Watch Out for in the latter half of 2026 – Read here

Akero execs reunite to advance long-acting psoriasis pill

Argenx acquires Forte for $2.2B to get hands on phase 2-stage vitiligo drug

InnoCare’s oral TYK2 inhibitor clears phase 3 psoriasis test

Sanofi halts development of troubled immune drug in eczema

Chasing Dupixent, a biotech aims to make better antibody drugs for eczema

Regeneron backs $75M series A for antibody upstart Infinimmune

Post-Conference Day

Explore the Agenda

Pre-Conference Day

Day, Month DD

Day One

Day, Month DD

Day Two

Day, Month DD

Post-Conference Day

Day, Month DD

No day selected

Track Heading

No day selected

Track Heading

No day selected

Track Name

No day/stream selected

Track Name

No day selected